Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gu-Shen Ding-Chuan-Wan for COVID-19 recovery phase with Fei-Pi-Qi-Xu syndrome
ChiCTR2000030937Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Gu-Shen Ding-Chuan-Wan in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Change in TCM syndrome score for Fei-Pi-Qi-Xu syndrome and Fatigue assessment scale results and change over time. Started Mar 2020; status: recruiting.
02
Drugs
Gu-Shen Ding-Chuan-Wan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000030937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030937.